Related by context. Frequent words. (Click for all words.) 64 mg BID 63 FOLFOX 63 peginterferon alfa 2b 63 mcg kg 62 evaluable 60 mg d 60 Secondary endpoints include 60 plus ribavirin 60 plus prednisone 60 FOLFIRI 60 laboratory abnormalities 59 interferon alfa 59 mg/m2 59 sustained virologic response 59 Secondary endpoints 59 dacarbazine 59 evaluable patients 59 events AEs 58 nonresponders 58 median PFS 58 decitabine 58 peginterferon 58 mg dose 58 neoadjuvant chemotherapy 58 metastatic renal cell carcinoma 57 refractory multiple myeloma 57 Median survival 57 mg kg 57 Adverse events 57 HCV genotype 1 57 HGS ETR1 57 P = .# 57 valopicitabine 57 placebo p = 57 discontinuations due 56 hypokalemia 56 limiting toxicity 56 plus methotrexate 56 pegylated interferon 56 dose cohorts 56 randomized Phase III 56 free survival PFS 56 mitoxantrone 56 HCV RNA 56 RECIST criteria 56 fluorouracil 56 lacosamide 56 n = 56 Taxotere ® 56 randomized #:# 56 Secondary endpoints included 56 peginterferon alfa 2a 55 cytogenetic response 55 noninferiority 55 Gemcitabine 55 vandetanib 55 placebo 55 unresectable 55 confidence interval CI 55 vicriviroc 55 fludarabine 55 seroconversion 55 REBETOL 55 TORISEL 55 febrile neutropenia 55 composite endpoint 55 p = #.# [004] 55 vinorelbine 55 secondary endpoint 55 Monotherapy 55 NRTI 55 LIALDA 55 prespecified 55 events SAEs 55 certolizumab pegol 55 mg m 55 PROMACTA 54 treatment emergent adverse 54 monotherapy 54 placebo p 54 multicenter randomized double 54 ONGLYZA 54 adefovir 54 adalimumab 54 blinded placebo controlled 54 infliximab 54 docetaxel 54 leukopenia 54 nasopharyngitis 54 pharmacodynamic 54 castration resistant prostate cancer 54 IU mL 54 6R BH4 54 sunitinib 54 hypomagnesemia 54 LVEF 54 undetectable viral load 53 imetelstat 53 gefitinib 53 etoposide 53 azacitidine